Physician profile
Peter C Foster
NPI 1275096927
$11,701.30
in general payments reported to CMS, 2019-2025
7 companies · $6,082 in 2025
The $6,082 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $260 · 2024: $5,359 · 2025: $6,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $880 · Education: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $880.48 |
| Education | $820.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,533.86 | 2024-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $723.48 | 2023-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Synecor Biomaterial |
| Silk Road Medical, INC. | $193.70 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Tela Bio, INC. | $139.05 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lemaitre Vascular, INC. | $59.65 | 2023-2025 | Artegraft Vascular Graft, Restoreflow |
| Boston Scientific Corporation | $35.38 | 2025 | Enroute Transcarotid Neuroprotection System |
| Ethicon US, LLC | $16.18 | 2025 | Prolene |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.